🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/08/2022 | 213,89 | 219,71 | 212,73 | 217,49 | +1,02% | 3,26% | 245.900 |
| 26/08/2022 | 221,32 | 221,80 | 214,59 | 215,30 | -2,48% | 3,26% | 304.800 |
| 25/08/2022 | 223,78 | 224,09 | 219,52 | 220,78 | -0,77% | 2,04% | 244.500 |
| 24/08/2022 | 228,05 | 228,05 | 218,75 | 222,49 | -1,77% | 4,08% | 379.600 |
| 23/08/2022 | 219,88 | 226,70 | 217,63 | 226,51 | +2,81% | 4,12% | 353.200 |
| 22/08/2022 | 224,32 | 224,61 | 218,80 | 220,31 | -1,84% | 2,59% | 201.000 |
| 19/08/2022 | 223,60 | 225,69 | 221,93 | 224,44 | +0,45% | 1,68% | 254.600 |
| 18/08/2022 | 222,24 | 223,61 | 218,63 | 223,44 | +0,82% | 2,24% | 230.100 |
| 17/08/2022 | 221,01 | 222,97 | 218,39 | 221,63 | -0,01% | 2,07% | 224.400 |
| 16/08/2022 | 219,36 | 223,44 | 218,72 | 221,66 | +1,51% | 2,15% | 333.400 |
| 15/08/2022 | 217,47 | 218,65 | 212,91 | 218,36 | +0,58% | 2,64% | 630.100 |
| 12/08/2022 | 220,66 | 224,06 | 215,41 | 217,10 | -1,50% | 3,92% | 556.500 |
| 11/08/2022 | 220,66 | 222,82 | 219,04 | 220,41 | -0,49% | 1,71% | 348.700 |
| 10/08/2022 | 220,15 | 221,90 | 217,63 | 221,49 | +1,06% | 1,94% | 224.600 |
| 09/08/2022 | 219,36 | 221,92 | 217,49 | 219,17 | +0,20% | 2,02% | 340.600 |
| 08/08/2022 | 220,44 | 222,95 | 211,99 | 218,73 | -1,32% | 4,97% | 574.700 |
| 05/08/2022 | 221,87 | 224,58 | 219,92 | 221,65 | +0,14% | 2,10% | 329.400 |
| 04/08/2022 | 225,81 | 229,94 | 221,22 | 221,35 | -3,14% | 3,86% | 383.300 |
| 03/08/2022 | 225,36 | 238,39 | 225,36 | 228,52 | +1,68% | 5,78% | 591.900 |
| 02/08/2022 | 226,18 | 227,78 | 223,11 | 224,75 | -0,24% | 2,06% | 369.600 |
| 01/08/2022 | 230,20 | 230,81 | 224,41 | 225,30 | -2,50% | 2,78% | 412.200 |
| 29/07/2022 | 228,55 | 231,19 | 226,55 | 231,07 | +0,47% | 2,03% | 368.300 |
| 28/07/2022 | 230,68 | 232,19 | 222,94 | 229,99 | -0,44% | 4,01% | 344.100 |
| 27/07/2022 | 229,57 | 232,41 | 226,46 | 231,00 | -0,19% | 2,59% | 288.900 |
| 26/07/2022 | 229,00 | 233,35 | 227,51 | 231,44 | +1,52% | 2,55% | 477.800 |
| 25/07/2022 | 226,45 | 229,00 | 224,06 | 227,98 | +1,12% | 2,18% | 300.200 |
| 22/07/2022 | 223,67 | 225,72 | 221,91 | 225,45 | -0,33% | 1,70% | 280.600 |
| 21/07/2022 | 226,14 | 227,89 | 224,32 | 226,20 | +0,03% | 1,58% | 408.000 |
| 20/07/2022 | 232,81 | 232,81 | 221,03 | 226,13 | -2,29% | 5,06% | 528.900 |
| 19/07/2022 | 235,99 | 239,75 | 217,42 | 231,43 | -1,14% | 9,46% | 1.018.500 |